How big is the Cardiac Biomarkers Market | Size, Share & Forecast to 2026

Q: How big is the Cardiac Biomarkers market?

The Cardiac Biomarkers Market was estimated at USD 12 billion in 2025 and is projected to reach USD 22.2 billion by 2032.

Q: What is driving the growth of this market?

Rising heart disease prevalence, early diagnosis demand, and innovation in rapid testing kits are fuelling growth.

Q: What are the key trends in the Cardiac Biomarkers industry?

High-sensitivity assays, integration with AI tools, remote monitoring, and point-of-care diagnostics.

Q: Who are the leading players in the cardiac biomarkers market?

Leading players include Roche, Abbott, Siemens, Thermo Fisher, and bioMérieux.

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA5627

Publication Date: Jul 2025

What is the size of the Cardiac Biomarkers Market?

According to 6Wresearch internal database and industry insights, Global Cardiac Biomarkers Market was estimated at USD 12 billion in 2025 and is projected to reach USD 22.2 billion by 2032, growing at a CAGR of 9.9% during the forecast period 2026–2032.

For detailed forecasts, data tables, and competitive benchmarking,
Explore the full Global Cardiac Biomarkers Market.

View Main Report Schedule Analyst Call

The growth of market is anticipated for strong growth driven by rising cardiovascular disease prevalence, increased demand for early diagnostics, and advancements in point-of-care testing technologies.

Key Growth Drivers of the Cardiac Biomarkers Market

Growing incidence of heart diseases and related health conditions globally
Increased awareness and government initiatives promoting preventive healthcare
Rising geriatric population susceptible to cardiac disorders
Technological advancements in rapid and high-sensitivity diagnostic assays
Expansion of point-of-care and home-based cardiac testing solutions

Cardiac Biomarkers Market Trends

Cardiac biomarkers market is moving forward with strong trends such as high-sensitivity troponin tests are gaining prominence for early diagnosis. This market is integrated with cardiac biomarker analysis with wearable and remote monitoring tools is emerging. AI-powered diagnostic platforms are supporting the better prediction and clinical decision-making. Further, multiplex assays are becoming more common in clinical labs.

Emerging Developments in the Cardiac Biomarkers Market

Cardiac biomarker market is seeing new developments with ongoing research is leading to the identification of novel biomarkers such as copeptin and ST2. Aside from these, the partnerships between diagnostic companies and hospitals are improving clinical workflow. Also, the regulatory approvals for lab-on-chip and portable biomarker detection devices are accelerating the market adoption, especially in low-resource settings.